To assess anti-GDF-15 treatment against human cancer in vivo, we reconstituted NOD/SCID/γc-/-/FcγR-/- mice with human umbilical cord-derived CD34+ human hematopoietic stem cells. This evidence concerns the gene FCGR2A and cancer.